(GBD 2019 Benign Prostatic Hyperplasia Collaborators) (November 2022)
In preclinical research settings, 5 Amino-1-MQ has been examined across a range of laboratory models, often in the context of: Published research summaries and references can be accessed via public scientific databases such as PubMed
If the answer is deeper tissue recovery, injections may be the form to discuss
It works by upregulating the body's own healing mechanisms, not by introducing exogenous hormones
Cagrilintide is investigational
Reported issues at therapeutic doses are mild and uncommon, and include local injection-site reactions, occasional dizziness, and transient changes in blood pressure [Sikiric et al., Inflammopharmacology, 2018]